Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial

Bensimon, G., Leigh, P.N., Tree, T. et al. (50 more authors) (2025) Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial. The Lancet. ISSN 0140-6736

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Bensimon, G.
  • Leigh, P.N.
  • Tree, T.
  • Malaspina, A.
  • Payan, C.A.M.
  • Pham, H.-P.
  • Klaassen, P.
  • Shaw, P.J.
  • Al Khleifat, A.
  • Amador, M.D.M.
  • Attarian, S.
  • Bell, S.M. ORCID logo https://orcid.org/0000-0002-2781-6478
  • Beltran, S.
  • Bernard, E.
  • Camu, W.
  • Corcia, P.
  • Corvol, J.-C.
  • Couratier, P.
  • Danel, V.
  • Debs, R.
  • Desnuelle, C.
  • Dimitriou, A.
  • Ealing, J.
  • Esselin, F.
  • Fleury, M.-C.
  • Gorrie, G.H.
  • Grapperon, A.-M.
  • Hesters, A.
  • Juntas-Morales, R.
  • Kolev, I.
  • Lautrette, G.
  • Le Forestier, N.
  • McDermott, C.J.
  • Pageot, N.
  • Salachas, F.
  • Sharma, N.
  • Soriani, M.-H.
  • Sreedharan, J.
  • Svahn, J.
  • Verber, N.
  • Verschueren, A.
  • Yildiz, O.
  • Suehs, C.M.
  • Saker-Delye, S.
  • Muller, C.
  • Masseguin, C.
  • Hajduchova, H.
  • Kirby, J. ORCID logo https://orcid.org/0000-0002-7468-5917
  • Garlanda, C.
  • Locati, M.
  • Zetterberg, H.
  • Asselain, B.
  • Al-Chalabi, A.
Copyright, Publisher and Additional Information:

© 2025 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Dates:
  • Published (online): 9 May 2025
  • Published: 9 May 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Funding Information:
Funder
Grant number
EUROPEAN COMMISSION - HORIZON 2020
633413
MOTOR NEURONE DISEASE ASSOCIATION
Kirby/Feb22/969-794
MOTOR NEURONE DISEASE ASSOCIATION
100177
MOTOR NEURONE DISEASE ASSOCIATION
Kirby/Feb22/969-794
Depositing User: Symplectic Sheffield
Date Deposited: 19 May 2025 11:31
Last Modified: 19 May 2025 11:31
Published Version: https://doi.org/10.1016/s0140-6736(25)00262-4
Status: Published online
Publisher: Elsevier BV
Refereed: Yes
Identification Number: 10.1016/s0140-6736(25)00262-4
Open Archives Initiative ID (OAI ID):

Export

Statistics